GO:0034775 glutathione transmembrane transport: Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034775 glutathione transmembrane transport is the biological process by which glutathione (GSH) is moved across a membrane.
• Glutathione is the most abundant non-protein thiol antioxidant in mammalian cells and is central to redox homeostasis, detoxification and drug metabolism.
• Transport of glutathione across membranes is required for its extracellular antioxidant and signaling roles, and for maintaining compartmentalized redox balance [2,4].
• ABCC transporters, CFTR and other ABC-family proteins have been linked to glutathione efflux and membrane transport in epithelial and other tissues [1,4,7].
• Dysregulated glutathione transport contributes to cystic fibrosis airway disease, chronic obstructive pulmonary disease and emphysema pathogenesis [4,7].
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of candidate glutathione transporter genes in relevant cell types [1,4].
Description
Glutathione transmembrane transport (GO:0034775) is the biological process in which the tripeptide glutathione (GSH) is translocated across a lipid bilayer. Glutathione is synthesized in the cytosol and is the principal non-protein thiol antioxidant, participating in redox buffering, xenobiotic detoxification and drug metabolism. Because GSH is charged and hydrophilic, it cannot freely diffuse across membranes; dedicated transport systems are therefore required to move it between intracellular compartments and into the extracellular space [2,4]. This transport process is essential for maintaining the distinct redox environments of the cytosol, mitochondria, endoplasmic reticulum and extracellular milieu [2,4]. In epithelial tissues, glutathione efflux across the apical membrane contributes to the antioxidant defense of the airway surface liquid, where it protects against inhaled oxidants and inflammatory oxidants [4,7]. In cystic fibrosis, impaired anion transport and altered glutathione handling are associated with defective mucociliary clearance and chronic inflammation [1,4]. Restoring glutathione transport and redox balance has therefore emerged as a therapeutic strategy in cystic fibrosis and chronic obstructive pulmonary disease [4,7]. For researchers, GO:0034775 provides a defined ontology node for annotating genes and proteins that mediate glutathione movement across membranes. Experimental dissection of this process requires tools that can manipulate candidate transporters and measure glutathione flux, making CRISPR-based cell models particularly valuable [1,4].
glutathione transmembrane transport At A Glance
| GO ID | GO:0034775 |
|---|---|
| GO term | glutathione transmembrane transport |
| Ontology | biological_process |
| Synonym | glutathione membrane transport; transmembrane glutathione transport |
| Definition | A process in which glutathione is transported across a membrane. |
| Major function | Translocation of glutathione across biological membranes to support redox homeostasis, detoxification and extracellular antioxidant defense [2,4]. |
| Substrates | Reduced glutathione (GSH) and related glutathione species. |
| Representative proteins | ABC transporters, CFTR and other membrane transport proteins implicated in glutathione handling [1,4,7]. |
| Associated diseases | Cystic fibrosis, chronic obstructive pulmonary disease and emphysema [4,7]. |
| Research methods | CRISPR knockout/knock-in models, glutathione flux assays, epithelial transport measurements and redox imaging [1,4]. |
What Is GO:0034775?
In simple terms, GO:0034775 describes the process of carrying glutathione across a cell membrane. According to the QuickGO definition, it is a process in which glutathione is transported across a membrane. The term is a biological_process and includes synonyms such as glutathione membrane transport and transmembrane glutathione transport. It covers the movement of glutathione from one side of a membrane to the other, whether that membrane is the plasma membrane or an intracellular organelle membrane, and it is distinct from glutathione biosynthesis or glutathione conjugation reactions.
Why Is glutathione transmembrane transport Important in Cell Biology?
Glutathione transmembrane transport is important because glutathione cannot cross membranes by simple diffusion, yet its protective and signaling functions depend on its distribution across cellular compartments and its release into extracellular fluids [2,4]. Defects in glutathione transport or in the transporters that mediate it can shift redox balance, impair detoxification and contribute to inflammatory lung disease [4,7]. Understanding GO:0034775 therefore connects basic redox biology to clinically relevant processes such as mucociliary clearance, epithelial defense and drug metabolism [1,2,4,7].
• Maintains compartment-specific redox balance by moving glutathione between cytosol, organelles and extracellular space.
• Supports extracellular antioxidant defense, including protection of airway surface liquid.
• Contributes to detoxification of xenobiotics and drug metabolites through glutathione-dependent pathways [2,8].
• Is mechanistically linked to cystic fibrosis airway disease and mucociliary transport defects [1,4].
• Is implicated in chronic obstructive pulmonary disease and emphysema pathogenesis via oxidative stress and CFTR dysfunction.
• Provides a targetable node for antioxidant therapies such as glutathione or bicarbonate nanoparticle delivery.
• Enables annotation of ABC transporter and CFTR family genes in functional genomics studies [1,5].
• Can be studied with CRISPR models to establish causal roles of candidate transporters [1,4].
• Relevant to aging biology through redox and mitochondrial homeostasis.
• Connects to analgesic and drug metabolism research because glutathione availability affects drug detoxification.
What Happens During glutathione transmembrane transport?
Substrate recognition and membrane association
In simple terms: The transporter first recognizes glutathione at the membrane.
Glutathione transmembrane transport begins when a membrane protein binds or otherwise engages glutathione at one face of the lipid bilayer. Because glutathione is hydrophilic and charged at physiological pH, its passage requires a proteinaceous pathway rather than free diffusion. ABC-family proteins and CFTR have been discussed as contributors to glutathione efflux and membrane handling in epithelial cells [1,4]. The specificity of this step determines whether reduced glutathione, oxidized glutathione or glutathione conjugates are preferentially moved.
Translocation across the lipid bilayer
In simple terms: The transporter carries glutathione from one side of the membrane to the other.
During translocation, the transporter undergoes conformational changes that expose glutathione alternately to the cytoplasmic and extracellular (or organellar) sides of the membrane. This step establishes the concentration gradient of glutathione across the membrane and is essential for maintaining distinct redox environments in different compartments [2,4]. In epithelial cells, apical glutathione efflux contributes to the antioxidant capacity of the airway surface liquid.
Coupling to ion and bicarbonate transport
In simple terms: Glutathione movement is often coordinated with ion transport.
Glutathione transport does not occur in isolation; it is functionally coupled to ion and fluid transport in epithelia [1,4]. CFTR, although classically a chloride and bicarbonate channel, has been linked to glutathione transport and redox regulation in the airway [1,7]. Nanoparticle-based delivery of glutathione and bicarbonate has been shown to improve mucociliary transport in cystic fibrosis epithelia, indicating that glutathione availability and ion transport are interdependent.
Extracellular glutathione pool and redox signaling
In simple terms: Once outside the cell, glutathione acts as an antioxidant and signal.
After translocation, glutathione enters the extracellular space, where it scavenges oxidants and participates in redox signaling [2,4]. S-nitrosoglutathione augmentation has been shown to control cigarette smoke-induced inflammatory-oxidative stress and to restore CFTR function in models of COPD-emphysema, linking extracellular glutathione species to disease pathogenesis. This extracellular pool is therefore a key functional output of GO:0034775 [2,7].
Recycling and gradient maintenance
In simple terms: Cells continuously restore glutathione gradients after transport.
To sustain glutathione transmembrane transport, cells must replenish intracellular glutathione through synthesis and recycling pathways. Glutathione homeostasis is maintained by a balance between synthesis, consumption, oxidation and transport, and disruption of this balance affects drug metabolism and detoxification [2,8]. Persistent maintenance of glutathione gradients is also relevant to healthy lifespan and aging in mouse models.
Key Genes Involved in GO:0034775 glutathione transmembrane transport
The following genes and proteins have been associated with glutathione handling, membrane transport or related redox and epithelial transport processes in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CFTR | Anion channel linked to glutathione transport and redox regulation in epithelia [1,7] | Cystic fibrosis and COPD models; glutathione efflux studies [1,4,7] |
| ABCC1 | ABC transporter implicated in glutathione conjugate efflux | Detoxification and multidrug resistance research |
| ABCC2 | ABC transporter involved in glutathione conjugate transport | Drug metabolism and hepatobiliary transport studies |
| ABCC3 | ABC transporter associated with glutathione conjugate efflux | Xenobiotic detoxification research |
| ABCC4 | ABC transporter linked to cyclic nucleotide and glutathione-related transport | Epithelial transport and redox studies |
| ABCC5 | ABC transporter implicated in nucleotide and glutathione conjugate transport | Transport assays and knockout models |
| GCLC | Catalytic subunit of glutamate-cysteine ligase in glutathione synthesis | Glutathione depletion and redox studies |
| GCLM | Modulatory subunit of glutamate-cysteine ligase | Regulation of glutathione synthesis |
| GSS | Glutathione synthetase, final step of glutathione synthesis | Glutathione homeostasis research |
| GGT1 | Gamma-glutamyl transferase, glutathione breakdown and recycling | Extracellular glutathione metabolism studies |
| SLC7A11 | Cystine/glutamate antiporter supporting glutathione synthesis | Oxidative stress and ferroptosis research |
| GSTP1 | Glutathione S-transferase for conjugation and detoxification [2,8] | Drug metabolism and cancer research [2,8] |
| GSTM1 | Glutathione S-transferase involved in xenobiotic detoxification [2,8] | Analgesic and drug metabolism studies |
| GSTT1 | Glutathione S-transferase family member | Detoxification and disease association studies |
| CISD2 | Mitochondria-associated protein linked to redox and lifespan regulation | Aging and glutathione-related homeostasis models |
| ASNA1 | Arsenite transporter homolog with ATP-binding properties | Transport mechanism and metal/redox studies |
| SLC25A | Mitochondrial carrier family members relevant to glutathione transport | Mitochondrial redox transport research |
How Is glutathione transmembrane transport Regulated?
Glutathione transmembrane transport is regulated at multiple levels. Substrate availability depends on glutathione synthesis and recycling, which are controlled by enzymes such as GCLC, GCLM, GSS and GGT1. Transport activity can be influenced by the expression and localization of ABC transporters and CFTR at the membrane [1,4]. Inflammatory and oxidative stress conditions, such as cigarette smoke exposure, alter glutathione species and CFTR function, thereby affecting transport-related redox balance. Drug metabolism pathways also consume glutathione and can indirectly regulate the size of the transportable glutathione pool. In addition, mitochondrial and redox-related proteins such as CISD2 have been linked to glutathione homeostasis and lifespan regulation in mice.
glutathione transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CFTR | Cystic fibrosis; airway redox and mucociliary transport [1,4] | CFTR knockout or point-mutation airway epithelial cells [1,4] |
| CFTR | COPD-emphysema; S-nitrosoglutathione and oxidative stress | Cigarette smoke extract-treated epithelial models |
| GSTP1 | Drug metabolism and detoxification [2,8] | GSTP1 knockout or overexpression cell lines [2,8] |
| GSTM1 | Analgesic and xenobiotic metabolism | GSTM1 knockout hepatocyte models |
| CISD2 | Aging and redox homeostasis | CISD2 transgenic or knockout mouse models |
Cystic fibrosis and airway redox imbalance
Cystic fibrosis is caused by mutations in CFTR, an anion channel that has also been linked to glutathione transport and redox regulation. Defective CFTR function is associated with impaired mucociliary transport, and glutathione and bicarbonate nanoparticle delivery has been shown to improve mucociliary transport in cystic fibrosis epithelia. These findings connect GO:0034775 to airway surface liquid redox biology and epithelial defense [1,4].
COPD and emphysema
Chronic obstructive pulmonary disease and emphysema involve cigarette smoke-induced inflammatory-oxidative stress. Augmentation of S-nitrosoglutathione has been reported to control this stress and to restore CFTR function in COPD-emphysema pathogenesis models. This places glutathione species and their membrane transport within the mechanistic framework of smoking-related lung disease.
Drug metabolism and analgesic toxicity
Glutathione is consumed during detoxification of drugs and their metabolites, and analgesics can deplete glutathione pools. Because glutathione transmembrane transport determines the distribution of glutathione between compartments, it can influence susceptibility to drug-induced oxidative injury [2,8]. This has practical implications for analgesic safety and for understanding interindividual differences in detoxification capacity.
Aging and redox homeostasis
Persistent levels of CISD2, a protein associated with mitochondrial and redox function, have been shown to extend healthy lifespan and delay aging in mice. Glutathione homeostasis and transport contribute to the redox environment that supports mitochondrial function, linking GO:0034775 to aging biology [2,6].
From glutathione transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate transporter required for glutathione efflux? | CRISPR knockout of the transporter in epithelial cells [1,4] |
| Does a specific CFTR mutation alter glutathione transport? | CFTR point-mutation knock-in cell lines [1,4] |
| Can a tagged transporter be tracked at the membrane? | Tagged knock-in of the transporter gene |
| Does overexpression of an ABC transporter increase glutathione flux? | Overexpression cell models |
| Which genes regulate glutathione-dependent redox balance? | CRISPR library screening in redox reporter cells |
| Does glutathione transport affect mucociliary transport? | Cystic fibrosis epithelial air-liquid interface models |
How to Study the glutathione transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Glutathione quantification | Intra- and extracellular glutathione levels | Redox and transport studies |
| Redox-sensitive reporters | Cellular redox state [2,4] | Live-cell imaging of glutathione transport |
| CRISPR knockout | Loss-of-function effects on transport [1,4] | Causal testing of candidate transporters |
| CRISPR point mutation | Effect of specific variants on transport | CFTR mutation studies |
| Tagged knock-in | Protein localization and trafficking | Membrane transporter tracking |
| Overexpression | Gain-of-function transport capacity | ABC transporter studies |
| CRISPR library screening | Genome-wide regulators of glutathione transport | Pathway discovery |
| Air-liquid interface epithelial culture | Apical transport and mucociliary function | Cystic fibrosis models |
Glutathione flux and redox assays
Measuring glutathione transport requires assays that quantify glutathione in extracellular and intracellular compartments. Redox-sensitive reporters and glutathione quantification methods can be used to assess the functional output of GO:0034775 [2,4]. These assays are often combined with epithelial transport measurements to link glutathione movement to mucociliary function.
CRISPR-based genetic perturbation
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate glutathione transporters [1,4]. For example, CFTR knockout or point-mutation cells can be used to examine how loss of CFTR function affects glutathione handling and redox balance [1,4]. Such models are essential for distinguishing correlation from causation in transport studies.
Epithelial transport and imaging
Epithelial cell models grown at air-liquid interface enable measurement of apical glutathione efflux and mucociliary transport. Imaging approaches can track redox reporters and membrane-localized transporters in live cells [1,4]. These methods connect molecular transport events to tissue-level physiology.
Omics and bioinformatics
Transcriptomic and proteomic profiling can identify genes whose expression correlates with glutathione transport capacity. Pathway enrichment using GO:0034775 helps interpret omics datasets in the context of redox and detoxification biology. Bioinformatics integration of transport annotations supports hypothesis generation for CRISPR screening.
How CRISPR Can Be Used to Study GO:0034775 glutathione transmembrane transport
Knockout
CRISPR knockout of candidate glutathione transporters such as CFTR or ABC-family genes can determine whether they are required for glutathione transmembrane transport [1,4]. Knockout epithelial cells can be assayed for changes in extracellular glutathione, redox balance and mucociliary transport. This approach provides direct loss-of-function evidence for GO:0034775 annotations.
Point Mutation
Point-mutation knock-in models allow study of disease-relevant variants, such as CFTR mutations, on glutathione transport and redox regulation. These models preserve endogenous regulatory context while introducing a specific amino acid change. They are useful for linking genotype to transport phenotype in cystic fibrosis research [1,4].
Knock-in
Tagged knock-in of transporter genes enables visualization and biochemical isolation of the transport machinery. Knock-in of reporter or affinity tags can reveal membrane localization and trafficking dynamics relevant to glutathione transport. This supports mechanistic studies of how transporters reach the membrane and function there.
Overexpression
Overexpression of candidate transporters can test whether increased protein levels enhance glutathione efflux or uptake. Such gain-of-function models complement knockout studies and help establish sufficiency. They are particularly useful for ABC transporters implicated in glutathione conjugate transport.
How EDITGENE Supports glutathione transmembrane transport Research
Researchers studying glutathione transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in glutathione movement, redox balance or disease-relevant epithelial function. Establishing causality requires well-controlled genetic models that can be assayed with transport and redox readouts [1,4].
Contact EDITGENE today to design your custom CRISPR model for glutathione transmembrane transport research.
Frequently Asked Questions About glutathione transmembrane transport
What is glutathione transmembrane transport?
Glutathione transmembrane transport (GO:0034775) is the biological process in which glutathione is moved across a membrane by dedicated transport proteins.
What is the GO ID for glutathione transmembrane transport?
The Gene Ontology ID is GO:0034775, under the biological_process aspect.
What genes are involved in glutathione transmembrane transport?
Genes linked to glutathione handling and transport include CFTR, ABC transporters such as ABCC1-ABCC5, and glutathione synthesis and metabolism genes such as GCLC, GCLM, GSS and GGT1 [1,2,4].
Why is glutathione transport important in cystic fibrosis?
CFTR dysfunction is associated with altered glutathione transport and redox balance, and glutathione plus bicarbonate nanoparticle delivery improves mucociliary transport in cystic fibrosis epithelia [1,4].
How is glutathione transported across membranes?
Because glutathione is hydrophilic and charged, it requires membrane transport proteins such as ABC transporters or CFTR-associated pathways rather than simple diffusion [2,4].
What diseases are associated with defective glutathione transport?
Cystic fibrosis, chronic obstructive pulmonary disease, emphysema and drug-induced oxidative injury have been linked to altered glutathione handling [4,7,8].
How can CRISPR be used to study glutathione transmembrane transport?
CRISPR knockout, point-mutation, knock-in and overexpression models can test whether candidate genes are required or sufficient for glutathione transport and redox balance [1,4].
What methods measure glutathione transport?
Glutathione quantification, redox-sensitive reporters, epithelial transport assays and omics approaches are commonly used to measure glutathione transport [2,4].
Is glutathione transport related to aging?
Glutathione homeostasis contributes to redox balance, and proteins such as CISD2 have been linked to healthy lifespan and aging in mice.
What is the difference between glutathione synthesis and glutathione transmembrane transport?
Glutathione synthesis produces glutathione inside cells, whereas glutathione transmembrane transport moves the synthesized glutathione across membranes.
Conclusion
GO:0034775 glutathione transmembrane transport defines the movement of glutathione across biological membranes, a process essential for redox homeostasis, detoxification and epithelial defense [2,4]. Its connections to cystic fibrosis, COPD and drug metabolism make it a clinically relevant ontology node [1,4,7,8]. CRISPR-based cell models provide a rigorous way to test the causal roles of candidate transporters and to advance therapeutic strategies targeting glutathione transport [1,4].
References
- 1. Hanssens LS et al.. 2021. CFTR Protein: Not Just a Chloride Channel?. Cells 10(11) PMID: 34831067
- 2. Jefferies H et al.. 2003. Glutathione.. ANZ J Surg 73(7):517-22 PMID: 12864828
- 4. Cho DY et al.. 2024. Glutathione and bicarbonate nanoparticles improve mucociliary transport in cystic fibrosis epithelia.. Int Forum Allergy Rhinol 14(6):1026-1035 PMID: 37975554
- 5. Kurdi-Haidar B et al.. 1996. Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporter.. Genomics 36(3):486-91 PMID: 8884272
- 6. Wu CY et al.. 2012. A persistent level of Cisd2 extends healthy lifespan and delays aging in mice.. Hum Mol Genet 21(18):3956-68 PMID: 22661501
- 7. Bodas M et al.. 2017. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.. Antioxid Redox Signal 27(7):433-451 PMID: 28006950
- 8. Lauterburg BH. 2002. Analgesics and glutathione.. Am J Ther 9(3):225-33 PMID: 11941382
